Like many other industry sectors, the bioscience space has been slow to embrace the digital future. Investing in and building out an integrated, enterprise-wide digital platform always played second fiddle to funding R&D, hiring, manufacturing and the commercial function. A Deloitte “Perspectives” piece perhaps framed the current state of digital transformation in the life sciences best, suggesting that organizations need to move “…from merely doing digital to being digital” or risk irrelevancy.
Lab Owl® a Key Contributor to Advanced Regenerative Manufacturing Institute’s Mission
Published on :consortium in 2019. Since that time, the Lab Owl product has been integrated into ARMI’s Tissue Foundry manufacturing process, and the Lab Owl team has made important contributions to several working groups tasked with solving some of the challenges facing tissue engineering and regenerative medicine manufacturing. These working groups include establishing ARMI’s Workforce Characteristics Charter; the Tissue Maturation and Bioreactor Charter; and the Cell Culture and Harvest Charter.
5 Questions With… 2020 Recap
Published on :In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.
5 Questions with Kurt Elam, Senior Director, Sales & Marketing for LabOwl
Published on :Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical experience, focused primarily on oncology, infectious disease, and critical care/ICU medicine. He has overseen and managed the successful launch of over 16 new FDA approved products/compounds or new indications, and worked to gain formulary approval in managed care organizations, thereby improving access for patients.
Experts Weigh in on the Role of Lab Automation and Sensor Technology in Advancing the Cell Therapy and Regenerative Medicine Fields
Published on :While there is tremendous excitement and ample investment around cell and gene therapy and regenerative medicine, several challenges, including scale-up, high manufacturing costs, and regulatory hurdles, continue to be impediments to the industry achieving its potential.
These Industry-Leading Companies & Experts Are Presenting at the Phacilitate World Stem Cell Summit
Published on :Stem Cell Experts from Maryland presenting at Phacilitate World Stem Cell Summit
2019’s Top 10 Most Read Biotech News Stories from the BioHealth Capital Region
Published on :Top 10 Biotech News Stories from 2019 from the BioHealth Capital Region on biobuzz.io
Maryland Pavilion to Showcase State’s Thriving Biotech Community at Annual BIO Convention
Published on :BIO 2019 Maryland Pavilion